News
News
New Pilot Study To Be Initiated by the End of 2023
Thursday, November 16, 2023
A clinical trial entitled "A Pilot Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer" will be initiated by the end of 2023.
Pancreatic Cancer Discovery Opens the Door for New Clinical Trial at Wilmot
Wednesday, November 15, 2023
Pancreatic cancer is tricky to manage because it spreads easily and early, and the tumors have a unique biological makeup. But, researchers made a breakthrough by learning about the genetic changes that occur during tumor migration — and also found a drug that can obstruct the process.
Read More: Pancreatic Cancer Discovery Opens the Door for New Clinical Trial at Wilmot